Literature DB >> 29668332

Neurological complications of Zika virus infection.

Francisco Javier Carod-Artal1,2.   

Abstract

INTRODUCTION: Zika virus (ZIKV) disease is a vector-borne infectious disease transmitted by Aedes mosquitoes. Recently, ZIKV has caused outbreaks in most American countries. Areas covered: Publications about neurological complications of ZIKV infection retrieved from pubmed searchers were reviewed, and reference lists and relevant articles from review articles were also examined. Vertical/intrauterine transmission leads to congenital infection and causes microcephaly and congenital ZIKV syndrome. ZIKV preferentially infects human neural progenitor cells and triggers cell apoptosis. ZIKV RNA has been identified in foetal brain tissue and brains of microcephalic infants who died; amniotic fluid and placentas of pregnant mothers; and umbilical cord, cerebro-spinal fluid and meninges of newborns. The increase in the number of Guillain-Barre syndrome (GBS) cases during the ZIKV outbreak in the Americas provides epidemiological evidence for the link between ZIKV infection and GBS. Less frequently reported ZIKV neurological complications include encephalitis/meningoencephalitis, acute disseminated encephalomyelitis, myelitis, cerebrovascular complications (ischemic infarction; vasculopathy), seizures and encephalopathy, sensory polyneuropathy and sensory neuronopathy. Analysis of GBS incidence could serve as an epidemiological 'marker' or sentinel for ZIKV disease and other neurological complications associated to ZIKV. Expert commentary: An expanding spectrum of neurological complications associated with ZIKV infection is being recognised.

Entities:  

Keywords:  Congenital Zika virus syndrome; Guillain-Barré syndrome; Zika virus; encephalitis; flavivirus; microcephaly; myelitis

Mesh:

Year:  2018        PMID: 29668332     DOI: 10.1080/14787210.2018.1466702

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  26 in total

Review 1.  Conserved and variable natural killer cell receptors: diverse approaches to viral infections.

Authors:  Leidy Y Bastidas-Legarda; Salim I Khakoo
Journal:  Immunology       Date:  2019-01-17       Impact factor: 7.397

Review 2.  An update on the aspects of Zika virus infection on male reproductive system.

Authors:  E D Borges; A A Vireque; T S Berteli; C R Ferreira; A S Silva; P A Navarro
Journal:  J Assist Reprod Genet       Date:  2019-05-30       Impact factor: 3.412

3.  Hippo Signaling Pathway Has a Critical Role in Zika Virus Replication and in the Pathogenesis of Neuroinflammation.

Authors:  Gustavo Garcia; Sayan Paul; Sara Beshara; V Krishnan Ramanujan; Arunachalam Ramaiah; Karin Nielsen-Saines; Melody M H Li; Samuel W French; Kouki Morizono; Ashok Kumar; Vaithilingaraja Arumugaswami
Journal:  Am J Pathol       Date:  2020-02-05       Impact factor: 4.307

4.  Zika vaccine pre-clinical and clinical data review with perspectives on the future development.

Authors:  Stephen J Thomas; Alan Barrett
Journal:  Hum Vaccin Immunother       Date:  2020-07-23       Impact factor: 3.452

5.  Emerging tropical neurological infections.

Authors:  Udaya K Ranawaka
Journal:  Clin Med (Lond)       Date:  2022-01       Impact factor: 2.659

6.  The Compound SBI-0090799 Inhibits Zika Virus Infection by Blocking De Novo Formation of the Membranous Replication Compartment.

Authors:  Laura Riva; Sarah Goellner; Scott B Biering; Chun-Teng Huang; Andrey N Rubanov; Uta Haselmann; Colin M Warnes; Paul D De Jesus; Laura Martin-Sancho; Alexey V Terskikh; Eva Harris; Anthony B Pinkerton; Ralf Bartenschlager; Sumit K Chanda
Journal:  J Virol       Date:  2021-09-01       Impact factor: 5.103

7.  Excretion of Cell-Free and Cell-Associated Zika Virus into Breast Milk of Infected Dams and Identification of Antiviral Factors.

Authors:  Sophie Desgraupes; Patricia Jeannin; Antoine Gessain; Pierre-Emmanuel Ceccaldi; Aurore Vidy
Journal:  Viruses       Date:  2022-04-20       Impact factor: 5.818

8.  Zika Virus Infection in the Developing Mouse Produces Dramatically Different Neuropathology Dependent on Viral Strain.

Authors:  Kevin K Noguchi; Brant S Swiney; Sasha L Williams; Jacob N Huffman; Katherine Lucas; Sophie H Wang; Kayla M Kapral; Amber Li; Krikor T Dikranian
Journal:  J Neurosci       Date:  2019-12-13       Impact factor: 6.167

9.  Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.

Authors:  Rachel P M Abrams; Adam Yasgar; Tadahisa Teramoto; Myoung-Hwa Lee; Dorjbal Dorjsuren; Richard T Eastman; Nasir Malik; Alexey V Zakharov; Wenxue Li; Muzna Bachani; Kyle Brimacombe; Joseph P Steiner; Matthew D Hall; Anuradha Balasubramanian; Ajit Jadhav; Radhakrishnan Padmanabhan; Anton Simeonov; Avindra Nath
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-23       Impact factor: 12.779

Review 10.  Zika virus: epidemiology, clinical aspects, diagnosis, and control of infection.

Authors:  Ahmad Karkhah; Hamid Reza Nouri; Mostafa Javanian; Veerendra Koppolu; Jila Masrour-Roudsari; Sohrab Kazemi; Soheil Ebrahimpour
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-08-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.